Dr. Gelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 NW 16th St 11heicoh
Miami, FL 33125Phone+1 305-575-7000Fax+1 888-720-1380
Summary
- Board certified ID/IM and at the center of the VHA response to COVID-19. Pandemic preparedness, informatics tools for decision support and analytics in infection control and antimicrobial stewardship. Helped build VA's national informatics tools for COVID-19 screening/triage. Regularly consulted by infection preventionists across the VA for advice on infection control matters related to COVID-19.
Education & Training
- Stanford Health Care2008
- University of WashingtonResidency, Internal Medicine, 2006 - 2008
- University of WashingtonInternship, Internal Medicine, 2005 - 2006
- University of Wisconsin School of Medicine & Public HealthClass of 2005
- University of Wisconsin-ExtensionPh.D., Organic Chemistry, 1998 - 2003
- Harvard UniversityAB, Chemistry and Physics, Magna Cum Laude, 1992 - 1996
- Harvard UniversityA.B., Chemistry and Physics, 1992 - 1996
Certifications & Licensure
- FL State Medical License 2023 - 2026
- NY State Medical License 2017 - 2024
- NJ State Medical License 2016 - 2023
- CA State Medical License 2008 - 2020
- WA State Medical License 2005 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Internal MedicineInfectious Diseases
Awards, Honors, & Recognition
- Physician of the Year - Partner in Collaboration James J. Peters VA Medical Center, 2020
- Friend of Pharmacy James J. Peters VA Medical Center, 2019
- K08 Career Development Award NIH, 2012
- Join now to see all
Clinical Trials
- Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics Start of enrollment: 2018 Jan 22
Roles: Contact
- Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA Start of enrollment: 2022 Mar 29
Roles: Contact
Publications & Presentations
PubMed
- 48 citationsSelective binding of TAR RNA by a Tat-derived beta-peptide.Michael A. Gelman, Sara N. Richter, Hong Cao, Naoki Umezawa, Samuel H. Gellman
Organic Letters. 2003-09-06 - 88 citationsBiocidal activity of polystyrenes that are cationic by virtue of protonation.Michael A. Gelman, Bernard Weisblum, David M. Lynn, Samuel H. Gellman
Organic Letters. 2004-01-27 - 48 citationsDesign and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ.Florentine U. Rutaganira, Melissa L. Fowler, Jacob A. McPhail, Michael A. Gelman, Khanh Nguyen
Journal of Medicinal Chemistry. 2016-02-26
Journal Articles
- Mixing the right hepatitis C inhibitor cocktailGelman, M. A.; Glenn, J. S., Trends in Molecular Medicine, 1/1/2010
- Biocidal activity of polystyrenes that are cationic by virtue of protonationGelman, M. A.; Weisblum, B.; Lynn, D. M.; Gellman, S. H., Org. Lett., 1/1/2004
- Selective binding of TAR RNA by a Tat-derived Beta-peptideGelman, M. A.; Richter, S.; Cao, H.; Umezawa, N.; Gellman, S. H.; Rana, T. M., Org. Lett., 1/1/2003
- Join now to see all
Books/Book Chapters
Lectures
- Jaundice and Acute Hepatitis in Rural ThailandSa Kaeo Provincial Hospital, Sa Kaeo, Thailand - 1/16/2006
Other
- Synthesis and biological applications of cationic Beta-peptides and styrenic copolymers (PhD thesis)Gelman, M. A. and Gellman S.H., Department of Chemistry, University of Wisconsin
1/1/2003 - Directed combinatorial organic chemistry in ligand design (undergraduate thesis)Schreiber S. L., Gelman, M. A., Department of Chemistry, Harvard University
1/1/1996
Press Mentions
- COVID Wizards: ID and EpidemiologyJune 17th, 2020
Grant Support
- K08 Career Development AwardNational Institute of Allergy and Infectious Diseases2012–Present
- Herman F. Lopata Hepatitis Postdoctoral FellowshipAmerican Liver Foundation2010–2011
Research History
- Postdoctoral Fellow/InstructorInfectious Diseases Fellowship Research, Stanford University, development of novel antiviral agents against hepatitis C virus2009 - 2015
- Graduate StudentPhD thesis research, Organic Chemistry, University of Wisconsin-Madison, Samuel H. Gellman group - synthesis and biological activity of beta-peptides and cationic polystyrene derivatives1998 - 2003
- UndergraduateUndergraduate research, Organic Chemistry, Harvard University, Stuart L. Schreiber group, directed combinatorial organic chemistry and computational ligand design1994 - 1996
Professional Memberships
- Member
- Member
- Member
Other Languages
- Hebrew, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: